Table 3.
Associated factors of hepatitis A virus seropositivity, stratified by hepatitis A vaccination status of study participants.
Parameters | Vaccinated participants (n = 65) | Unvaccinated participants (n = 235) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariable analysis* | Multivariable analysis* | Univariable analysis* | Multivariable analysis* | |||||||||
Odds ratio | 95% CI | P | Adjusted odds ratio | 95% CI | P | Odds ratio | 95% CI | P | Adjusted odds ratio | 95% CI | P | |
Age group | ||||||||||||
1.0–5.9 years | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
6.0–10.9 years | 1.80 | 0.27–11.86 | 0.54 | 2.52 | 0.29–22.28 | 0.41 | 1.67 | 0.53–5.25 | 0.38 | 1.62 | 0.48–5.43 | 0.43 |
11.0–18.0 years | 0.33 | 0.07–1.65 | 0.18 | 0.71 | 0.09–5.85 | 0.75 | 2.87 | 0.99–8.34 | 0.05 | 1.71 | 0.44–6.56 | 0.44 |
Male sex | 1.39 | 0.36–5.37 | 0.63 | 0.90 | 0.16–5.03 | 0.91 | 1.54 | 0.69–3.43 | 0.29 | 1.78 | 0.75–4.22 | 0.19 |
BMI category | ||||||||||||
Normal | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Overweight | 2.00 | 0.22–18.39 | 0.54 | 7.13 | 0.36–142.72 | 0.20 | 4.08 | 1.58–10.55 | 0.004 | 5.00 | 1.82–13.73 | 0.002 |
Obese | 2.50 | 0.28–22.49 | 0.14 | 5.47 | 0.30–98.29 | 0.25 | 1.19 | 0.41–3.49 | 0.75 | 1.09 | 0.35–3.42 | 0.88 |
Number of people sharing participant’s bedroom, per one person increase | 2.47 | 1.31–4.67 | 0.005 | 3.23 | 1.34–7.80 | 0.009 | 0.67 | 0.48–0.95 | 0.02 | 0.70 | 0.44–1.12 | 0.14 |
BMI body mass index, Ref reference group, 95% CI 95% confidence interval.
*Univariable logistic regression analysis was performed to identify associated factors of hepatitis A virus seropositivity among study participants. Covariate with P < 0.20 which was number of people sharing participant’s bedroom as well as the well-known prespecified confounding factors, including age, sex and body mass index were incorporated in the multivariable logistic regression analysis.